Mechanism of sickle cell disease-specific venous thromboembolism

镰状细胞病特异性静脉血栓栓塞的机制

基本信息

  • 批准号:
    10611915
  • 负责人:
  • 金额:
    $ 66.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Program Director/Principal Investigator (Last, First, Middle) Pawlinski, Rafal and Key, Nigel Abstract Venous thromboembolism (VTE) is the third most common form of cardiovascular disease after myocardial infarction and ischemic stroke, with approximately 900,000 cases annually in the United States. VTE may present clinically as deep vein thrombosis (DVT) and/or pulmonary embolism (PE). However, it is unknown why some patients present with symptomatic DVT, while others present with PE. In recent years, it has been established that individuals with sickle cell disease (SCD), as well as carriers for SCD -- who are said to have sickle cell trait -- are at increased risk of VTE. Interestingly and unusually, in both sickle cell disease and trait, a skewed distribution in the proportions of patients with DVT and PE (in favor of PE) is observed. We have termed this phenomenon “the sickle cell paradox”. SCD is due to an inherited mutation in hemoglobin that is expressed exclusively in red blood cells (RBCs). Therefore, in this proposal, we postulate that a greater understanding of the mechanism of VTE in SCD, as well as an explanation for the sickle cell paradox, will be explained by a detailed study of the role of sickle RBCs in VTE. To address this question, we will utilize animal models of SCD with experimentally induced venous thrombi, while concurrently studying the qualitative aspects of blood clots formed from the blood of patients with SCD ex vivo. Towards this goal, we will address the following specific aims: in Aim 1, we will determine the effect of RBCs on venous thromboembolism in a mouse model of SCD. We expect that partial RBC exchange will result in smaller, more stable DVTs and a reduced incidence of PE. In Aim 2, we will investigate how sickle RBCs enhance thrombin generation in SCD. In the third Aim, we will determine the cellular and molecular mechanisms that attenuate sensitivity of sickle clots to fibrinolysis. We anticipate this effect is mediated both by the inherited defect in SCD RBCs, but also the fact that platelets in patients with SCD are over-activated. Finally, in Aim 4, we will determine whether reduction of platelet numbers reduces VTE and restores normal susceptibility to fibrinolysis in sickle mice and SCD patients undergoing chronic RBC exchange. With an annual worldwide SCD birth rate of more than 300,000 (and an estimated 250 million individuals with sickle trait), a greater mechanistic understanding of VTE in sickle cell disorders is a high priority. OMB No. 0925-0001/0002 (Rev. 03/16 Approved Through 10/31/2018) Page Continuation Format Page
项目总监/主要研究者(最后一名、第一名、中间名)Pawlinski、Rafal和Key、奈杰尔 摘要 静脉血栓栓塞(VTE)是仅次于心肌梗死的第三种最常见的心血管疾病。 梗死和缺血性中风,在美国每年约有900,000例。VTE可能存在 临床上称为深静脉血栓形成(DVT)和/或肺栓塞(PE)。然而,不知道为什么有些人 患者表现为有症状的DVT,而其他患者表现为PE。近年来, 患有镰状细胞病(SCD)的人,以及SCD的携带者--他们被认为具有镰状细胞特征, 患静脉血栓栓塞的风险增加。有趣而不同寻常的是,在镰状细胞病和性状中, 观察到DVT和PE患者比例的分布(有利于PE)。我们称之为 镰状细胞悖论(Sickle Cell Paradox)SCD是由于血红蛋白的遗传突变, 仅存在于红细胞(RBC)中。因此,在本提案中,我们假定, SCD中静脉血栓栓塞的机制,以及镰状细胞悖论的解释,将由一个 详细研究镰状红细胞在VTE中的作用。为了解决这个问题,我们将利用SCD的动物模型 实验诱导静脉血栓,同时研究血凝块的定性方面, 由SCD患者的血液离体形成。为达致这个目标,我们会处理以下的具体问题: 目的:在目的1中,我们将确定红细胞对SCD小鼠模型中静脉血栓栓塞的影响。 我们预计部分红细胞交换将导致更小,更稳定的DVT和PE的发生率降低。在 目的2,我们将研究镰状红细胞如何增强SCD中凝血酶的产生。在第三个目标中,我们将 确定降低镰状凝块对纤维蛋白溶解敏感性的细胞和分子机制。我们 预期这种效应是由SCD RBC中的遗传缺陷介导的,而且事实上, 患有SCD的患者过度活跃。最后,在目标4中,我们将确定血小板数量的减少是否 减少VTE并恢复镰状小鼠和SCD患者对纤维蛋白溶解的正常敏感性, RBC交换每年全球SCD出生率超过30万(估计有2.5亿人 因此,对镰状细胞疾病中VTE的机制性理解是一个高度优先事项。 OMB编号0925-0001/0002(2016年3月修订版,批准至2018年10月31日)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nigel S. Key其他文献

Validation of Townes As Mice As a Model of Chronic Kidney Disease and Venous Thrombosis Associated with Sickle Cell Trait
  • DOI:
    10.1182/blood-2023-186635
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Malgorzata Kasztan;Steven P Grover;Fatima Trebak;Mohammad O Sako;Nigel S. Key;Rafal Pawlinski
  • 通讯作者:
    Rafal Pawlinski
Adults with Severe or Moderately Severe Hemophilia B Receiving Etranacogene Dezaparvovec in the HOPE-B Phase 3 Clinical Trial Continue to Experience a Stable Increase in Mean Factor IX Activity Levels and Durable Hemostatic Protection after 24 Months’ Follow-up
  • DOI:
    10.1182/blood-2022-166135
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Steven W. Pipe;Frank W.G. Leebeek;Michael Recht;Nigel S. Key;Susan Lattimore;Giancarlo Castaman;Michiel Coppens;David Cooper;Robert Gut;Sergio Slawka;Stephanie Verweij;Ricardo Dolmetsch;Yanyan Li;Paul E. Monahan;Wolfgang A. Miesbach
  • 通讯作者:
    Wolfgang A. Miesbach
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency
导致异常剪接和因子 V 缺乏的明显同义 F5 突变的表征
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    F. Nuzzo;C. Bulato;B. Nielsen;Kristy Lee;Simone J.H. Wielders;Paolo Simioni;Nigel S. Key;E. Castoldi
  • 通讯作者:
    E. Castoldi
78: Variant Hemoglobin May Affect Erythropoietin Response in African-Americans Receiving Hemodialysis
  • DOI:
    10.1053/j.ajkd.2010.02.085
  • 发表时间:
    2010-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Vimal K. Derebail;Patrick H. Nachman;Nigel S. Key;Heather Ansede;Ronald J. Falk;Abhijit V. Kshirsagar
  • 通讯作者:
    Abhijit V. Kshirsagar

Nigel S. Key的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nigel S. Key', 18)}}的其他基金

Mechanism of sickle cell disease-specific venous thromboembolism
镰状细胞病特异性静脉血栓栓塞的机制
  • 批准号:
    10184626
  • 财政年份:
    2021
  • 资助金额:
    $ 66.1万
  • 项目类别:
Mechanism of sickle cell disease-specific venous thromboembolism
镰状细胞病特异性静脉血栓栓塞的机制
  • 批准号:
    10381739
  • 财政年份:
    2021
  • 资助金额:
    $ 66.1万
  • 项目类别:
Mechanisms of Venous Thromboembolism in Cancer
癌症静脉血栓栓塞的机制
  • 批准号:
    8307478
  • 财政年份:
    2008
  • 资助金额:
    $ 66.1万
  • 项目类别:
Mechanisms of Venous Thromboembolism in Cancer
癌症静脉血栓栓塞的机制
  • 批准号:
    7904072
  • 财政年份:
    2008
  • 资助金额:
    $ 66.1万
  • 项目类别:
Mechanisms of Venous Thromboembolism in Cancer
癌症静脉血栓栓塞的机制
  • 批准号:
    8117261
  • 财政年份:
    2008
  • 资助金额:
    $ 66.1万
  • 项目类别:
Mechanisms of Venous Thromboembolism in Cancer
癌症静脉血栓栓塞的机制
  • 批准号:
    8403088
  • 财政年份:
    2008
  • 资助金额:
    $ 66.1万
  • 项目类别:
Mechanisms of Venous Thromboembolism in Cancer
癌症静脉血栓栓塞的机制
  • 批准号:
    7691277
  • 财政年份:
    2008
  • 资助金额:
    $ 66.1万
  • 项目类别:
Catheter Directed Thrombolytic Therapy in Deep Vein Thrombosis
深静脉血栓的导管定向溶栓治疗
  • 批准号:
    7041961
  • 财政年份:
    2003
  • 资助金额:
    $ 66.1万
  • 项目类别:
PREVENT: Prevention of Recurrent Venous Thromboembolism
预防:预防复发性静脉血栓栓塞
  • 批准号:
    7041926
  • 财政年份:
    2003
  • 资助金额:
    $ 66.1万
  • 项目类别:
Tissue factor in hemophilia
血友病中的组织因子
  • 批准号:
    6642372
  • 财政年份:
    2002
  • 资助金额:
    $ 66.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了